Renal Resistive Index Detects Early Diabetic Kidney Damage in Children with Type 1 Diabetes: Study
Researchers have found in a new study that the Renal Resistive Index (RRI) detects early diabetic kidney damage in children with Type 1 Diabetes Mellitus.
The study, published in Cureus, highlights that in children with Type 1 Diabetes Mellitus, a Renal Resistive Index of 0.7 or higher can indicate early diabetic nephropathy even before urine albumin levels rise. Although 88.5% of the participants were normoalbuminuric (having normal levels of albumin in urine), 12.2% had elevated Renal Resistive Index values. Elevated Renal Resistive Index and urine albumin excretion were associated with increased blood urea and serum creatinine levels. Additionally, older age, a longer duration of diabetes, and abnormal lipid profiles (including high total cholesterol and triglyceride levels) were linked to a higher risk of developing diabetic nephropathy. Diabetic nephropathy is the most common microvascular complication in individuals with Type 1 Diabetes Mellitus.
This study aimed to assess the role of the Renal Resistive Index in the early detection of diabetic nephropathy in children with Type 1 Diabetes Mellitus. The study was conducted on 122 children diagnosed with Type 1 Diabetes Mellitus. Researchers analyzed several parameters: the age and gender of patients, the duration of diabetes, the number of episodes of diabetic ketoacidosis, serum creatinine, serum urea, urine albumin excretion, glycated hemoglobin levels, and the mean Renal Resistive Index of both kidneys The study included 60 males (49%) and 62 females (51%), with a male-to-female ratio of 0.96:1.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.